2024 Latin America Blood Typing, Grouping and Infectious Disease NAT Screening Market - 22 Countries - 2023 Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays
This unique report from LeadingMarketResearch.com provides information and analysis
not available from any other published source.
The database from LeadingMarketResearch.com provides the 2023 supplier shares and strategies by country, the 2023-2028 volume and sales forecasts for over 40 immunohematology and NAT assays, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including:
Blood Typing and Grouping TestsABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)
Infectious Disease Screening TestsAIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT
CountriesArgentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
The companies analyzed in the report include:Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio
Grifols
Hologic
Immucor
LabCorp
Proteome Sciences
Quest Diagnostics
QuidelOrtho
Roche
Siemens Healthineers
Tecan
Thermo Fisher
Please note:The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.